Introduction rheumatoid arthritis, insulin-dependent diabetes mellitus and Pemphigus vulgaris (PV) is a rare, autoimmune, bullous chronic active hepatitis. Recently, an association of PV with dermatosis. The disease affects all races and both sexes, infertility was described (Ouahes et al., 1997) . appears in middle age and rarely affects children. Jewish PV is extremely rare in pregnancy, and with the addition of people, especially Ashkenazi (central or eastern European) our case, only 27 reported cases can be found in the English Jews, have an increased susceptibility to PV (Korman, 1990) .
literature. We report the case of a patient with PV who Predisposition to pemphigus is linked to genetic factors:
conceived during the active phase of the disease, required high first-degree relatives of patients are more susceptible to the doses of corticosteroids for control, and gave birth to a predevelopment of autoimmune diseases (Firooz et al., 1994) , term, but otherwise healthy, appropriate-for-gestational-age certain major histocompatability complex (MHC) class II (AGA) newborn. molecules are more common in patients with PV (specifically, an HLA-DR4 allele) (Bhol et al., 1996) and finally, pemphigus Case report occurs in patients with other disorders characterized by immunological disturbances such as myasthenia gravis and A 32-year-old Ashkenazi Jewish woman, with a history of removal of basal cell carcinoma from scalp and right breast, lupus erythematosus (Cruz et al., 1987) . The pathogenesis is linked to the presence of autoantibodies directed against was admitted to the Dermatology Department because of multiple skin lesions and throat pain that persisted for over a desmoglein 3, a desmosome transmembrane glycoprotein belonging to the cadherin family (Joly et al., 1997) . These month. The lesions included pustules and erosions over the oral mucosa, including the epiglottis, and over the skin of the autoantibodies cause blisters which result from loss of cellcell adhesion in the basal and suprabasal layers of the deeper arms, thorax, abdomen and thighs. The diagnosis of PV was confirmed by histological examination, direct immunofluoresepidermis, with keratinocytes in the superficial layers of the cence-detected, intercellular deposition of Ig-G and C3, and better-known autoimmune diseases, such as systemic lupus erythematosus (Kaufman et al., 1988) . Our patient clearly pemphigus antibody titres that were positive by indirect immunofluorescence. Prednisone, 100 mg/day was initiated; demonstrated disease flare-up during the period of conception and early pregnancy, with difficulty in controlling the disease after 8 days the dose was increased to 120 mg/day for 15 days, and the patient was discharged on 80 mg/day with at that time. As shown in our patient, improvement in disease control during the third trimester may well be explained by improvement in both vesicles and wellbeing.
Two weeks after diagnosis and beginning of treatment, the rising endogenous corticosteroid production by the chorion and consequent immunosuppression (Weinberg, 1984) . patient had her last menstrual period. An intrauterine pregnancy was diagnosed by ultrasound with a crown-rump length of Transplacental transmission of PV Ig-G antibodies from mother to fetus may result in clinical manifestations in the 4 cm, dating the pregnancy 5 days earlier than that estimated by the last menstrual period. Therefore, the patient must have neonate (Wasserstrum and Laros, 1983) . Previous reports suggested a high incidence of skin lesions in the neonate (up conceived 8-9 weeks after the first symptoms of PV.
The woman continued prednisone therapy during pregnancy, to 61%). This high incidence of skin lesions, not reflected in our case, may represent over-publication of reports on neonates which was tapered to 15 mg/day. During the 13th week of gestation, she was hospitalized due to a severe flare-up of her with PV lesions (Ruach et al., 1995) . Neonatal PV has not been reported to progress to adulthood, and if the lesions do disease. This included vesicles and erosions over the skin of the neck, abdomen, back, breasts, and thighs, this time with appear on the neonate they tend to improve spontaneously within 3 weeks (Chowdhury and Natarajan, 1998) . Furtherno mucosal involvement. The patient was discharged with a prednisone dosage of 50 mg/day. The disease was controlled more, there is a lack of association between the clinical manifestations of the disease in mother and newborn. Another with no appearance of new lesions and slow improvement in existing lesions throughout the remainder of her pregnancy.
case was reported (Hern et al., 1998) in which the mother had oral disease without cutaneous involvement, whereas the child Pregnancy follow-up was normal regarding blood pressure examinations, maternal weight gain, and glucose tolerance presented with cutaneous blisters. PV may also be associated with a more adverse neonatal test. Amniocentesis was performed and demonstrated a male fetus with normal karyotype. Repeated ultrasonographic foloutcome, such as fetal growth restriction and preterm births. Of the 26 previously reported cases of PV in pregnancy, four low-up showed normal fetal growth (abdominal circumference -50th percentile; head circumference -40th percentile ended in intrauterine fetal death. All of these cases were associated with severe, active and difficult to control maternal and femur length -50th percentile). Intrauterine echocardiography, performed because of a 'golf ball' finding, showed mild disease (Terpstra et al., 1979; Green et al., 1982; Wasserstrum and Laros, 1983; Ross et al., 1986) . As in our case, there is thickening of one chorda tendinae in the right ventricle, with no haemodynamic significance. no obvious relationship between maternal disease severity and neonatal outcome (Merlob et al., 1986) . The only adverse The patient was admitted to our labour unit because of premature rupture of the membranes in her 33rd week of neonatal outcome in our case was premature rupture of membranes and delivery of a 33-week AGA, pre-term fetus. gestation. Fetal heart monitoring showed a single variable deceleration, after which it was reactive. Oxytocin induction
The aetiology of pre-term premature rupture of membranes (PPROM) which led to preterm delivery in the reported case of labour resulted in vaginal delivery. A male infant weighing 2270 g (AGA) was born, with Apgar scores of 9 at 1 minute may be related to the vigorous steroid therapy administered to the patient during her pregnancy. This connection has been and 10 at 5 min. Cord blood gases were normal.
The premature newborn was admitted to the neonatal intenspreviously described (Laskin et al., 1997) , where a significant increase was shown in preterm delivery, premature labour and ive care unit because of his age and weight. Apart from a transient event of hypoglycaemia, which was effectively treated PPROM in pregnant women treated with prednisone (0.5-0.8 mg/kg) and aspirin (100 mg/day) in comparison with those with i.v. glucose, and phototherapy due to indirect hyperbilirubinaemia, the newborn was otherwise healthy, without manigiven placebo. As low-dose aspirin is not associated with prematurity, the authors related the adverse outcome of the festations of PV.
reported pregnancies to corticosteroid treatment. Management of PV in pregnancy is similar to that in nonDiscussion pregnant women. High dose prednisone (60-360 mg/day) for several weeks and gradual tapering to a maintainence dose is In a retrospective study (Ouahes et al., 1997) , eight of nine patients suffering from PV failed to conceive. Four patients usually successful, as previously described (Hern et al., 1998) and as shown in this case. Although no increase in congenital had luteal phase defects, four had follicle stimulating hormone defects and anti-sperm antibodies were detected in two patients.
malformations has been reported (as discussed by Hern et al., 1998) , corticosteroid treatment in pregnancy has been associOnly one became pregnant, but only during full remission. Notably, none of the eight patients conceived even after ated, as in our case, with PPROM and preterm births (Laskin et al., 1997) . Therefore, the management in pregnancy should discontinuation of medications (corticosteroids, azathioprine or cyclophosphamide). In contrast, our patient conceived involve individual balancing of the risks of the disease and its complications against the potential adverse effects of therapy during disease flare-up, implying that active disease does not necessarily cause infertility.
on both mother and child. Immunosuppressive drugs should be withheld although azathioprine may be added (Hayashi, Pregnancy may precipitate or aggravate PV, as reported in Pemphigus vulgaris in pregnancy Rosenberg, F.R., Sanders, S. and Nelson, C.T. (1976) Pemphigus. A 20-year 1990) . Plasmapheresis has been proposed as a treatment review of 107 patients treated with corticosteroids. Arch. Dermatol., 112, option during pregnancy (Metzker and Merlob, 1990) , but this 962-970. treatment is still experimental.
Ross, M.G., Kane, B., Frieder, R. et al. (1986) (Goldberg et al., 1993) . In our patient there was no involvement wound healing of a Caesarean section, as reported previously (Daniel et al., 1995) .
Received on August 9, 1999; accepted on February 2, 2000 In summary, we report a woman who conceived during a flare-up of PV, was treated by corticosteroids, had another flare-up towards the end of her first trimester, carried her pregnancy to the 33rd week, and delivered a pre-term, AGA, healthy newborn with no PV manifestations.
